• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人间充质基质细胞向骨骼谱系的定向分化与其形态发生能力无关。

Commitment of human mesenchymal stromal cells to skeletal lineages is independent of their morphogenetic capacity.

作者信息

Marín-Llera Jessica Cristina, García-García Damián, Garay-Pacheco Estefania, Adrian Cortes-Morales Victor, Montesinos-Montesinos Juan Jose, Chimal-Monroy Jesus

机构信息

Medicina Genómica y Toxicología Ambiental, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Coyoacan 04510, Mexico.

Laboratorio de Células Troncales Mesenquimales, Unidad de Investigación Médica en Enfermedades Oncológicas, Hospital de Oncología Centro Medico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico.

出版信息

World J Stem Cells. 2023 Jul 26;15(7):701-712. doi: 10.4252/wjsc.v15.i7.701.

DOI:10.4252/wjsc.v15.i7.701
PMID:37545756
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10401422/
Abstract

BACKGROUND

Mesenchymal stromal cells (MSCs) are multipotent cell populations obtained from fetal and adult tissues. They share some characteristics with limb bud mesodermal cells such as differentiation potential into osteogenic, chondrogenic, and tenogenic lineages and an embryonic mesodermal origin. Although MSCs differentiate into skeletal-related lineages , they have not been shown to self-organize into complex skeletal structures or connective tissues, as in the limb. In this work, we demonstrate that the expression of molecular markers to commit MSCs to skeletal lineages is not sufficient to generate skeletal elements .

AIM

To evaluate the potential of MSCs to differentiate into skeletal lineages and generate complex skeletal structures using the recombinant limb (RL) system.

METHODS

We used the experimental system of RLs from dissociated-reaggregated human placenta (PL) and umbilical cord blood (UCB) MSCs. After being harvested and reaggregated in a pellet, cultured cells were introduced into an ectodermal cover obtained from an early chicken limb bud. Next, this filled ectoderm was grafted into the back of a donor chick embryo. Under these conditions, the cells received and responded to the ectoderm's embryonic signals in a spatiotemporal manner to differentiate and pattern into skeletal elements. Their response to differentiation and morphogenetic signals was evaluated by quantitative polymerase chain reaction, histology, immunofluorescence, scanning electron microscopy, and hybridization.

RESULTS

We found that human PL-MSCs and UCB-MSCs constituting the RLs expressed chondrogenic, osteogenic, and tenogenic molecular markers while differentially committing into limb lineages but could not generate complex structures . MSCs-RL from PL or UCB were committed early to chondrogenic lineage. Nevertheless, the UCB-RL osteogenic commitment was favored, although preferentially to a tenogenic cell fate. These findings suggest that the commitment of MSCs to differentiate into skeletal lineages differs according to the source and is independent of their capacity to generate skeletal elements or connective tissue . Our results suggest that the failure to form skeletal structures may be due to the intrinsic characteristics of MSCs. Thus, it is necessary to thoroughly evaluate the biological aspects of MSCs and how they respond to morphogenetic signals in an context.

CONCLUSION

PL-MSCs and UCB-MSCs express molecular markers of differentiation into skeletal lineages, but they are not sufficient to generate complex skeletal structures .

摘要

背景

间充质基质细胞(MSCs)是从胎儿和成人组织中获得的多能细胞群体。它们与肢芽中胚层细胞具有一些共同特征,例如具有分化为成骨、软骨生成和肌腱生成谱系的潜力以及胚胎中胚层起源。尽管MSCs可分化为与骨骼相关的谱系,但它们尚未像在肢体中那样自组织形成复杂的骨骼结构或结缔组织。在这项研究中,我们证明使MSCs定向分化为骨骼谱系的分子标志物的表达不足以生成骨骼成分。

目的

使用重组肢体(RL)系统评估MSCs分化为骨骼谱系并生成复杂骨骼结构的潜力。

方法

我们使用了来自解离后重新聚集的人胎盘(PL)和脐带血(UCB)MSCs的RL实验系统。收获细胞并在沉淀中重新聚集后,将培养的细胞引入从早期鸡肢芽获得的外胚层覆盖物中。接下来,将这个填充有细胞的外胚层移植到供体鸡胚的背部。在这些条件下,细胞以时空方式接收并响应外胚层的胚胎信号,从而分化并形成骨骼成分的模式。通过定量聚合酶链反应、组织学、免疫荧光、扫描电子显微镜和杂交技术评估它们对分化和形态发生信号的反应。

结果

我们发现构成RLs的人PL-MSCs和UCB-MSCs表达软骨生成、成骨和肌腱生成的分子标志物,同时在不同程度上定向分化为肢体谱系,但无法生成复杂结构。来自PL或UCB的MSCs-RL早期定向分化为软骨生成谱系。然而,UCB-RL的成骨定向更受青睐,尽管优先倾向于肌腱生成细胞命运。这些发现表明,MSCs定向分化为骨骼谱系的情况因来源而异,并且与其生成骨骼成分或结缔组织的能力无关。我们的结果表明,未能形成骨骼结构可能是由于MSCs的内在特性。因此,有必要全面评估MSCs的生物学特性以及它们在特定环境中对形态发生信号的反应方式。

结论

PL-MSCs和UCB-MSCs表达分化为骨骼谱系的分子标志物,但它们不足以生成复杂的骨骼结构。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8df/10401422/3405c208ab45/WJSC-15-701-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8df/10401422/583e5542cf76/WJSC-15-701-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8df/10401422/e503262b3bed/WJSC-15-701-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8df/10401422/db1c2a926a41/WJSC-15-701-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8df/10401422/ddda21ed37bd/WJSC-15-701-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8df/10401422/3405c208ab45/WJSC-15-701-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8df/10401422/583e5542cf76/WJSC-15-701-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8df/10401422/e503262b3bed/WJSC-15-701-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8df/10401422/db1c2a926a41/WJSC-15-701-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8df/10401422/ddda21ed37bd/WJSC-15-701-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8df/10401422/3405c208ab45/WJSC-15-701-g005.jpg

相似文献

1
Commitment of human mesenchymal stromal cells to skeletal lineages is independent of their morphogenetic capacity.人间充质基质细胞向骨骼谱系的定向分化与其形态发生能力无关。
World J Stem Cells. 2023 Jul 26;15(7):701-712. doi: 10.4252/wjsc.v15.i7.701.
2
Recombinant Limb Assay as Organoid Model.重组肢体分析作为类器官模型
Front Cell Dev Biol. 2022 Apr 26;10:863140. doi: 10.3389/fcell.2022.863140. eCollection 2022.
3
[Biological characteristics and induced differentiation ability of in vitro expanded umbilical cord blood mesenchymal stem cells].[体外扩增脐血间充质干细胞的生物学特性及诱导分化能力]
Zhonghua Er Ke Za Zhi. 2005 Jul;43(7):499-502.
4
Umbilical cord blood-derived mesenchymal stem cells consist of a unique population of progenitors co-expressing mesenchymal stem cell and neuronal markers capable of instantaneous neuronal differentiation.脐带血来源的间充质干细胞由一群独特的祖细胞组成,这些祖细胞共同表达间充质干细胞和神经元标志物,能够进行瞬时神经元分化。
Stem Cell Res Ther. 2012 Dec 19;3(6):57. doi: 10.1186/scrt148.
5
Bone morphogenetic protein-2 enhances the osteogenic differentiation capacity of mesenchymal stromal cells derived from human bone marrow and umbilical cord.骨形态发生蛋白-2增强源自人骨髓和脐带的间充质基质细胞的成骨分化能力。
Int J Mol Med. 2017 Mar;39(3):654-662. doi: 10.3892/ijmm.2017.2872. Epub 2017 Feb 1.
6
Differences in the intrinsic chondrogenic potential of equine umbilical cord matrix and cord blood mesenchymal stromal/stem cells for cartilage regeneration.马脐带基质和脐带血间充质基质/干细胞在软骨再生中的内在成软骨潜力的差异。
Sci Rep. 2018 Sep 14;8(1):13799. doi: 10.1038/s41598-018-28164-9.
7
SCA-1/Ly6A Mesodermal Skeletal Progenitor Subpopulations Reveal Differential Commitment of Early Limb Bud Cells.SCA-1/Ly6A中胚层骨骼祖细胞亚群揭示了早期肢芽细胞的不同分化情况。
Front Cell Dev Biol. 2021 Jul 16;9:656999. doi: 10.3389/fcell.2021.656999. eCollection 2021.
8
Chondrogenic commitment of human umbilical cord blood-derived mesenchymal stem cells in collagen matrices for cartilage engineering.人脐带血来源间充质干细胞在胶原基质中的软骨向分化及其在软骨组织工程中的应用。
Sci Rep. 2016 Sep 8;6:32786. doi: 10.1038/srep32786.
9
Skeletal myogenic differentiation of mesenchymal stem cells isolated from human umbilical cord blood.从人脐带血中分离的间充质干细胞的骨骼肌生成分化
Stem Cells. 2004;22(4):617-24. doi: 10.1634/stemcells.22-4-617.
10
Potency testing of mesenchymal stromal cell growth expanded in human platelet lysate from different human tissues.在来自不同人体组织的人血小板裂解物中生长扩增的间充质基质细胞的效力测试。
Stem Cell Res Ther. 2016 Aug 25;7(1):122. doi: 10.1186/s13287-016-0383-3.

本文引用的文献

1
Role of MSC-derived small extracellular vesicles in tissue repair and regeneration.间充质干细胞衍生的小细胞外囊泡在组织修复和再生中的作用。
Front Cell Dev Biol. 2023 Mar 1;10:1047094. doi: 10.3389/fcell.2022.1047094. eCollection 2022.
2
Recent advances to enhance the immunomodulatory potential of mesenchymal stem cells.近期增强间充质干细胞免疫调节潜能的研究进展。
Front Immunol. 2022 Sep 23;13:1010399. doi: 10.3389/fimmu.2022.1010399. eCollection 2022.
3
Immunomodulatory Mechanisms of Mesenchymal Stem Cells and Their Potential Clinical Applications.
间充质干细胞的免疫调节机制及其潜在的临床应用。
Int J Mol Sci. 2022 Sep 2;23(17):10023. doi: 10.3390/ijms231710023.
4
Recombinant Limb Assay as Organoid Model.重组肢体分析作为类器官模型
Front Cell Dev Biol. 2022 Apr 26;10:863140. doi: 10.3389/fcell.2022.863140. eCollection 2022.
5
Artificial Kidney Capsule Packed with Mesenchymal Stem Cell-Laden Hydrogel for the Treatment of Rhabdomyolysis-Induced Acute Kidney Injury.人工肾胶囊包被间充质干细胞水凝胶用于治疗横纹肌溶解症诱导的急性肾损伤。
ACS Biomater Sci Eng. 2022 Apr 11;8(4):1726-1734. doi: 10.1021/acsbiomaterials.1c01595. Epub 2022 Mar 18.
6
Chicken Recombinant Limbs Assay to Understand Morphogenesis, Patterning, and Early Steps in Cell Differentiation.鸡的重组肢体分析,用于研究形态发生、模式形成以及细胞分化的早期步骤。
J Vis Exp. 2022 Jan 12(179). doi: 10.3791/63183.
7
Mesenchymal stromal cell-based therapy for cartilage regeneration in knee osteoarthritis.基于间充质基质细胞的膝关节骨关节炎软骨再生治疗。
Stem Cell Res Ther. 2022 Jan 10;13(1):14. doi: 10.1186/s13287-021-02689-9.
8
Bone marrow-derived mesenchymal stem cells transplantation ameliorates renal injury through anti-fibrotic and anti-inflammatory effects in chronic experimental renovascular disease.骨髓间充质干细胞移植通过抗纤维化和抗炎作用改善慢性实验性血管性肾病的肾损伤。
Biomed J. 2022 Aug;45(4):629-641. doi: 10.1016/j.bj.2021.07.009. Epub 2021 Jul 29.
9
Understanding the Cellular and Molecular Mechanisms That Control Early Cell Fate Decisions During Appendicular Skeletogenesis.了解在附肢骨骼发生过程中控制早期细胞命运决定的细胞和分子机制。
Front Genet. 2019 Oct 11;10:977. doi: 10.3389/fgene.2019.00977. eCollection 2019.
10
Mesenchymal Stem Cell-Based Immunomodulation: Properties and Clinical Application.基于间充质干细胞的免疫调节:特性与临床应用
Stem Cells Int. 2018 Jun 14;2018:3057624. doi: 10.1155/2018/3057624. eCollection 2018.